• Home
  • Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.

Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis.

Author List
Liu C, Wang L, Zhuang J, Liu L, Zhou C, Feng F, Sun C
Publication
Annals of oncology : official journal of the European Society for Medical Oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/114670282
Publication Year
2018
PubMed ID
29788163
Publication Title
Liu C, Wang L, Zhuang J, Liu L, Zhou C, Feng F, Sun C. Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis. Ann Oncol. 2018 05 01; 29(5):1329-1330.